Please Wait...

Clinical Trial Articles

Whether you're interested in the current clinical trial management industry trends or want to know more about the latest FDA requirements, our collection of clinical trial articles will keep you up to date on what's happening now in clinical research news.

Clinical Trial Articles


Essential ToolsCo-authored by Mélanie Bodnar-Wachtel, PhD and Tanja Schubert, PhD

This article is taken from European Biopharmaceutical Review April 2017, pages 34-38. © Samedan Ltd.

Three-Fold Solution

This article is taken from International Clinical Trials August 2017, pages 46-48. © Samedan Ltd


Kristin Mauri, PMP, Enterprise Quality Management of Clinical Trials, April 2016.

Clare Jackson, Utku Ozdemir, Liz Moench.  Take a Chance.  ICT.  February 2016.


deVillafranca C, Andrus J. Technology Considerations To Increasing Clinical Trial Efficiencies With Risk-Based Monitoring. Life Science Leader. January 31, 2014.

Lin EH, Lenz HJ, Saleh MN, Mackenzie MJ, Knost JA, Pathiraja K, Langdon RB, Yao S, Lu BD.  A randomized, phase II study of the anti-insulin-like growth factor receptor type 1 (IGF-1R) monoclonal antibody robatumuma

Herron D. The New Road of Cardio-Oncology in Clinical Development. Applied Clinical Trials. April 1, 2014.


O'Neal M, Strafaci J, Scarimbolo R, and Van Heertum R. A Paradigm in Evolution. European Pharmaceutical Contractor (EPC) March 2013.

Borradaile K, Duffy K, O'Neal M. A Potential New Approach to Assessing PFS in Solid Tumor Studies. International Clinical Trials, May 2013.


Yu HJ, Miller CG, Flitcraft D. Metrics in Medical Imaging: Changing the Picture. ACRP: The Monitor. August 2012.


van Meurs P, Miller CG. Image Conscious: New FDA Guidance. Samedan Ltd. 2011 Dec: 24-28.

Spano Lander A and Lander, Reta C Rupich. No Limits: The Evolution of DXA. International Clinical Trials, February, 2011.


Ahmad H.

Borradaile K, Robert F, O'Neal M, Byrne K.

Webber B.


Weinstein M. An Albatross and an Opportunity. View on Clinical Operations. 2009 Jun.


Claypool, B.  Functional outsourcing: a better alternative to traditional outsourcing and EDC. Next Generation Pharmaceutical. 2007.


Reiber J, Heyrich G, van Weert A. A Period of Refinement. European Pharmaceutical Contractor (EPC). 2006;100-102.


van Weert A and Reiber J.

Kradjian S, Baratelle A, Einstein SG, Kaslow DCDevelopment of a Charter for an Endpoint Assessmen

Miller CG, Noever K.

van Weert A, Reiber J.


Miller C, Noever K. Scanning data for clinical information. Good Clinical Practices Journal. 2003. 10;9:21-24.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Join @bioclinica's Research Dev. Dir. Marieke Cajal, PhD @adpdnet 3/18 where she will speak on patient engagement…
bioclinica (22 hours ago)
Still on the fence about #eSource? Here R some key considerations & inside tips for successful implementation & how…
bioclinica (Yesterday)
Almost here! #ASCPT2018 Tour central Florida's premier Phase 1 facility at our Open House 3/22! Meet our team & see…
bioclinica (Yesterday)
RT @FDAWomen: Today we welcomed minority health stakeholders during FDA’s first Minority Health Listening Session. Thank you for this discu…
bioclinica (Yesterday)
RT @melfass: The House has rejected the "Right to Try" bill, opponents of which said would have compromised the #clinicaltrials process. cc…
bioclinica (Yesterday)
RT @eClinical_Jen: Here what the FDA has to say on using Microsoft Excel for Clinical Trial data: #eHealth #Pharm…
bioclinica (Yesterday)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen